Post-earnings recap
Reported
Thu, Jul 30, 2026
EPS actual
$4.99
EPS est.
$4.79
EPS surprise
+4.26%
1-day move
+2.73%
Labcorp Holdings Inc. is a leading health care company that provides comprehensive laboratory services and diagnostics. With a market cap of $26 billion, it plays a crucial role in health care by helping physicians and patients make informed decisions based on accurate test results.
Last quarter
In Q1-2026, Labcorp reported an EPS of $4.25, exceeding estimates by 3.81%. However, revenue details were not disclosed, and the stock experienced a slight decline the following day.
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+2.87%
Avg 1-day reaction
+1.25%
Analysts expect Labcorp to report solid earnings with an EPS of $4.63 and revenue of $3.8 billion. The company has a strong track record of beating earnings estimates, which may lead to positive market reactions.
Bull case
If Labcorp exceeds expectations, it could signal strong demand for its services, leading to increased investor confidence and a potential stock price rally.
Bear case
Conversely, if the company fails to meet the consensus estimates, it may raise concerns about its growth prospects, resulting in a negative reaction from investors.
Key metrics to watch
EPS
$4.63Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.
Revenue
$3.8BTotal revenue reflects the company's ability to generate sales and is critical for assessing growth.
The print will turn on these.
Q1
Will Labcorp's EPS exceed the consensus estimate of $4.63?
A beat on EPS could reinforce investor confidence and lead to a positive stock reaction, given the company's strong history of exceeding estimates.
Q2
What are the revenue figures for this quarter?
Revenue insights are crucial to understanding Labcorp's growth trajectory and overall business health, especially since prior revenue details were not disclosed.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±13.6%
Why consensus could be wrong
The Street may be underestimating the potential for Labcorp to exceed EPS expectations due to its strong historical performance and the increasing demand for lab services.
Supporting evidence
Labcorp has consistently beaten EPS estimates in the past, with a 100% beat rate over the last eight quarters.
The options market is pricing a larger move than historically realized, suggesting that investors are bracing for significant news.
The company's recent performance trends indicate a potential for continued growth, which may not be fully reflected in current estimates.
Key risk
If Labcorp's revenue comes in significantly above $3.8 billion, it could challenge the current consensus and shift investor sentiment.
Pre-commit to what would confirm each case.
This quarter's performance is under scrutiny as investors seek clarity on Labcorp's growth amid a competitive health care landscape.
Bull confirmed if
An EPS of $4.70 or higher would confirm strong operational performance and investor confidence.
Bear confirmed if
An EPS below $4.60 could indicate potential challenges in growth and profitability.
What the market is pricing for the move.
Implied Move
±10.59%
Historical Avg
±4.18%
The options market is pricing in a significant move around the earnings announcement, indicating heightened investor uncertainty.
Options price a 10.59% move but the stock has averaged only 4.18% over the last 8 quarters — setup is rich.
ATM IV
0.3%
30d HV
19.1%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 13 of 29 (45%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
101.81%
of float
Insider
0.35%
of float
Holders
1,441
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
6,574,261 sh · $2.1B
8.11%
2.0%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Labcorp beats expectations, history suggests a potential stock increase of around 1.95%, confirming positive market sentiment.
In line / cautious
If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious investor sentiment.
Miss
If Labcorp misses earnings expectations, history suggests a potential decline of around 1.95%, raising concerns about future growth.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
4
0 buys·4 sells
Members
1
House only
Est. Notional
$103,004.00–$295,000.00
disclosed dollar ranges
Most Active Members
4 trades
The lines on the call that would change the story.
Vanguard Capital Management LLC
5,362,254 sh · $1.7B
6.61%
-0.3%
Victory Capital Management Inc.
4,837,573 sh · $1.5B
5.96%
4.6%
State Street Corporation
3,907,656 sh · $1.2B
4.82%
1.1%
Vanguard Portfolio Management LLC
3,678,798 sh · $1.1B
4.54%
-0.1%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net selling
Recent Transactions
Traded Aug 25, 2026 · disclosed Sep 9, 2026
$100,001.00–$250,000.00
Traded Aug 7, 2026 · disclosed Sep 9, 2026
$1,001.00–$15,000.00
Traded Aug 6, 2026 · disclosed Sep 9, 2026
$1,001.00–$15,000.00
Traded Aug 5, 2026 · disclosed Sep 9, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.